Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Medicine, Science, and the Law
|
August 6, 2003
The Shipman inquiry: a progress report
Caroline Swift
JMIR Diabetes
|
May 20, 2026
Predicting Treatment Failure With Sodium-Glucose Cotransporter-2 Inhibitors in People With Type 2 Diabetes: Novel Artificial Intelligence and Machine Learning Approach
Doyoung Kwak, Xi Tan, Yuanjie Liang, et al.
Clinical Therapeutics
|
March 31, 2021
Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population
Jay Visaria, Chioma Uzoigwe, Caroline Swift, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 9, 2026
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Angelo Navas, Joshua Noone, Nathan Laney, et al.
Advances in Therapy
|
April 30, 2026
Cardiometabolic and Renal Outcomes in Semaglutide Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study
Xi Tan, Wan-Lun Tsai, Yuanjie Liang, et al.
Current Medical Research and Opinion
|
October 22, 2025
Comparative effectiveness of GLP-1 RAs and other glucose-lowering therapies among Medicare Advantage beneficiaries with T2D and ASCVD
Xi Tan, Yuanjie Liang, Lin Xie, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2026
Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States
Xi Tan, Yuanjie Liang, Lin Xie, et al.
Diabetes Research and Clinical Practice
|
September 11, 2025
Comparative effectiveness of OW GLP-1 RAs and other glucose-lowering therapies among Medicare beneficiaries with T2D and ASCVD
Xi Tan, Joanna Harton, Cynthia Gutierrez, et al.
American Journal of Preventive Cardiology
|
January 30, 2026
Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
James Amamoo, Lin Xie, Andrea Steffens, et al.
Clinical Therapeutics
|
January 18, 2025
Real-World Treatment Patterns Among US Patients With Type 2 Diabetes Mellitus Initiating Treatment With Once Weekly Semaglutide for Diabetes
Caroline Swift, Monica Frazer, Andrew Sargent, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Medicine, Science, and the Law
|
August 6, 2003
The Shipman inquiry: a progress report
Caroline Swift
JMIR Diabetes
|
May 20, 2026
Predicting Treatment Failure With Sodium-Glucose Cotransporter-2 Inhibitors in People With Type 2 Diabetes: Novel Artificial Intelligence and Machine Learning Approach
Doyoung Kwak, Xi Tan, Yuanjie Liang, et al.
Clinical Therapeutics
|
March 31, 2021
Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population
Jay Visaria, Chioma Uzoigwe, Caroline Swift, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 9, 2026
Semaglutide and Cardiovascular Outcomes in People with Type 2 Diabetes: A SUSTAIN-6 Post Hoc Analysis by Weight Loss Category
Angelo Navas, Joshua Noone, Nathan Laney, et al.
Advances in Therapy
|
April 30, 2026
Cardiometabolic and Renal Outcomes in Semaglutide Users with Type 2 Diabetes Achieving Glycemic and Weight Goals: An Observational Cohort Study
Xi Tan, Wan-Lun Tsai, Yuanjie Liang, et al.
Current Medical Research and Opinion
|
October 22, 2025
Comparative effectiveness of GLP-1 RAs and other glucose-lowering therapies among Medicare Advantage beneficiaries with T2D and ASCVD
Xi Tan, Yuanjie Liang, Lin Xie, et al.
Diabetes, Obesity & Metabolism
|
January 9, 2026
Comparison of cardiovascular outcomes between once-weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States
Xi Tan, Yuanjie Liang, Lin Xie, et al.
Diabetes Research and Clinical Practice
|
September 11, 2025
Comparative effectiveness of OW GLP-1 RAs and other glucose-lowering therapies among Medicare beneficiaries with T2D and ASCVD
Xi Tan, Joanna Harton, Cynthia Gutierrez, et al.
American Journal of Preventive Cardiology
|
January 30, 2026
Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes
James Amamoo, Lin Xie, Andrea Steffens, et al.
Clinical Therapeutics
|
January 18, 2025
Real-World Treatment Patterns Among US Patients With Type 2 Diabetes Mellitus Initiating Treatment With Once Weekly Semaglutide for Diabetes
Caroline Swift, Monica Frazer, Andrew Sargent, et al.
Page
of 2